Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Given Average Rating of “Buy” by Analysts

Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Rating) has been assigned a consensus recommendation of “Buy” from the ten ratings firms that are covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $20.06.

CURLF has been the subject of several analyst reports. Benchmark initiated coverage on shares of Curaleaf in a research note on Friday, February 25th. They issued a “buy” rating and a $12.00 price objective for the company. Cantor Fitzgerald decreased their price target on shares of Curaleaf from $16.50 to $15.50 and set an “overweight” rating for the company in a research note on Friday, March 4th. Needham & Company LLC decreased their price target on shares of Curaleaf from $17.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, March 4th. Wolfe Research began coverage on shares of Curaleaf in a research note on Friday, January 7th. They set a “peer perform” rating for the company. Finally, Stifel Nicolaus decreased their price target on shares of Curaleaf from C$31.00 to C$25.00 in a research note on Monday, March 7th.

CURLF traded down $0.14 on Friday, hitting $6.61. The company had a trading volume of 394,662 shares, compared to its average volume of 698,968. Curaleaf has a 12-month low of $5.35 and a 12-month high of $15.47. The business’s fifty day simple moving average is $7.08 and its 200 day simple moving average is $8.62.

Curaleaf (OTCMKTS:CURLF – Get Rating) last announced its quarterly earnings data on Thursday, March 3rd. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.02) by ($0.02).

Curaleaf Company Profile (Get Rating)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements.

Featured Stories